596 filings
Page 8 of 30
EFFECT
25gxsanj1u3y9v68l06
5 Jun 17
Notice of effectiveness
12:00am
424B3
xzp73gixavv9y5pk4
5 Jun 17
Prospectus supplement
12:00am
CORRESP
2x5dqtecffdv
2 Jun 17
Correspondence with SEC
12:00am
UPLOAD
75c7v473lpivmxh
23 May 17
Letter from SEC
12:00am
8-K
sg2ftaa5q6
22 May 17
Elite Pharmaceuticals Acquires Trimipramine ANDA
12:00am
D
70kk b8ek
10 May 17
$41.6M in equity, sold $800K, 1 investor
12:00am
8-K
zmc9op
2 May 17
Entry into a Material Definitive Agreement
12:00am
8-K/A
ri7 5hwzpwwn6rb
1 May 17
Entry into a Material Definitive Agreement
12:00am
8-K
1rgx ywacld6dal
28 Apr 17
Entry into a Material Definitive Agreement
12:00am
8-K
bzxjljwnqn5wgf2p
9 Feb 17
Elite Pharmaceuticals, Inc. Reports Results for Third Quarter of Fiscal Year 2017
12:00am
424B3
qh44r
9 Feb 17
Prospectus supplement
12:00am
8-K
6xpcb8 0z
22 Dec 16
Elite Provides Update on SequestOxâ„¢ New Drug Application
12:00am
CT ORDER
qqwb6ymp ye5e9dpxji7
22 Dec 16
Confidential treatment order
12:00am
424B3
3p56ybxne3zv qai
9 Nov 16
Prospectus supplement
12:00am